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were processed by a non linear anisotropic filter and LV edges were identified using an 
active contour algorithm, guided by image gradient. End-diastole and end-systole were 
identified based on R wave synchronization and cavity size, respectively. In both meth- 
ods, LV volumes were calculated by the modified Simpson's rule. A commercially avail- 
able automatic image analysis method was utilized for endocardial detection in MRI (Fast 
Cine, Leiden University version 4.0). Manual analysis showed a good correlation with 
MRI volumes (correlation coefficient r= 0.88); using this automatic approach the corraia- 
fion was still good (r = 0.82); however, LV diastolic and systolic volumes were higher for 
MRI (206 ± 96m1. and 148 ± 105 ml ) than for contrast echo assessed both manually (177 
± 88 mL and 108 ± 73, p= <.001) and automatically (179 ± 104m1. and 107 ± 79 ml. , 
p=.<001). In conclusion, automatic endocardisf border delineation is feasible on contrast 
enhanced images. Despite manual detection on contrast images showed a better corre- 
lation with MRI for LV contour analysis, preliminary results show that this method may 
represent a promising approach for automatic LV function assessment. 
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1144MP-130 QuanUtsUve Three-Dimensional Intravaecular 
Ultrasound: Improvements Toward Semi-Automated 
Border Detection Including the Stent Border 
Jouka Di!kstre, Gerhard Koning, Joan C. Tuinenburg, Pranobo V. Oemrawsingh, Johan 
H.C. Reiber, Leiden University Medical Center, Leiden, The Netherlands. 
Background: IntreVascular UltraSound (IVUS) is a catheter-based technique, which 
provides real-time high-resolution images of the entire arterial wall. The technique is 
used often to monitor the stent placement or to visualize in-stent restenosis. Automation 
of the boundary detection of the stent, lumen, and vessel reduces the required analysis 
time and the subjectivity of the manual tracing procedure. The three-dimensional recon- 
struction permits an advanced assessment of the morphology. 
Methods: The (semi-)automated approach is a combination of transversal and longitudi- 
nal contour detection techniques and is based on a model of the vessel and uses knowl- 
edge about the morphologic structures. The stent contour is detected based on the high 
intensity of the stent struts as compared to other structures and their expected location in 
the vessel wall based on an approximately cimuiar model. The detection method itself is 
able to perform corrections based a continuously three-dimensional structure. 
Results: In a set of 150 slices from different pullback sedas (acquired with Boston Scien- 
tific and EndoSonics equipment) the automatically detected stent boundaries were com- 
pared to manually drawn stent boundaries. The comparison of the cross-sectional stent 
areas for the manually traced and automatically detected boundadss resulted in an r- 
value of 0.99. In a set of 50 pullback runs (acquired with Endosonica equipment) the 
entire stented segment was analyzed automatically and the most distal and the most 
proximal slice in a continuous series of slices containing stent struts was selected to 
assess the stent length. The companson of these distances with the original stent lengths 
resulted in an average overestimation of 0.35 +/- 1.42 mm by IVUS. The start and end 
point of a stent is not well defined because the catheter moves in and out the stent, due 
to cardiac motion. 
Conclusion: Due to the flexible use of more than two longitudinal cutpianes and the 
advanced knowledge-guided contour detection approech, the new IVUS analysis system 
has proven to be suitable for clinical research studies. The inclusion of the stant bound- 
ary is very useful for stent studies e.g. to study the effect of drug coated stents. 
YOUNG INVESTIGATORS AWARDS COMPETITION 
411 Young Investigators Awards: Clinical 
Investigations 
Monday, March 18, 2002, 4:00 p.m.-5:30 p.m. 
Georgia World Congress Center, Room 257W 
4:00 p.m. 
411-1 A Prospective, Bl inded DeterminaUon of the Natural 
History of Aspir in Resistance Among Stable Cardiac 
Patients 
Patricia A. Gum. Kandica Kottke-Marchant, Eric J. Topoi, The C/eve/and C/inic 
Foundation, C/eveiand, Ohio. 
Background. Aspirin resistance, as defined by comprehensive, ax vivo piatalet function 
testing as well as presumed clinical unresponsiveness to aspirin, has been previously 
reported by our group and others. However, little information exists linking the laboratory 
documentation of aspirin resistance and long-term clinical events. 
Methods. We prospectively enrolled 326 stable cardiac patients from 1997 to 1999 on 
aspidn (325 mg/day for > 7 days) and no other antiplatalst agents. We tested them for 
aspidn sensitivity by optical piatelat aggregation using adenosine diphosphata (ADP) and 
arachidonic acid (AA) and followed them for clinical events. The primary outcome was 
the composite of death, myocardial infarction (MI), or carebrovascuiar accident (CVA). 
Mean follow-up was 679 ± 185 days. Aspirin resistance was defined as a mean aggrega- 
tion of > 70% with 10 p. M ADP and _> 20% with 0.5 rag/ml hA. 
Results. Of the patients studied, 17 (5.2%) were aspirin resistant and 309 (94.8%) were 
not aspirin resistant. Dudng long-term follow-up, aspirin resistance was associated with a 
significantly increased risk of death, MI, or CVA compared to patients who were aspidn 
sensitive (24% vs 10%, HR 3.12, 95% CI (1.10-8.90), p=0.03). Stratified multivadata 
analyses identified elevated piatelet count, advancing age, history of congestive heart 
failure and aspirin resistance to be independently associated with major adverse long- 
term outcomes (HR for aspirin resistance 4.14, 95% CI (1.42-12.06), p=0.009). 
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Conclusion. This study is the first prospective determinant of the natural history of aspi- 
rin resistance, documenting a greater than 2-fold increase in the risk of major adverse 
events associated with aspirin resistance. 
4:15 p.m. 
411-2 Loss of Thrombomodulin Expression Impairs Vein Graft 
Thromboreslstance 
Antony Y. Kim. Kenneth Lee Baughman, Peter L. Walinsky, Frank D. Kolodgie, C. E. 
Bean, Jason Sperry, Clayton Deming, Eric Peck, Jay Shake, Gregory Ang, Chades 
Eamon, Rsnu Virmani, Jeffrey Rada, Johns Hopkins Schoo/ of Medicine, Baltimore, 
Mary~and. 
Background: Thrombosis is the major cause of eady vein graft failure. The aim of this 
study was to determine whether alterations in the expression of the anticoagulant pro- 
teins, thrombomodulin (TM) and the endothelial call protein C receptor (EPCR), impair 
endothelial thromboresistance and contribute to vein graft failure. Methods and 
Results: Immunohistochamical nalysis of autologous rabbit vein grafts revealed that 
the expression of TM, but not EPCR, was reduced by 98% 3 days after implantation, with 
gradual but incomplete recovery by 42 days. This resulted in up to a 95% reduction in the 
capacity of the grafts to activate protein C and was associated with increased bound 
thrombin activity, that peaked on day 7 at 28.7" 3.8 mU/cm 2 and persisted for over 14 
days. Restoration of TM expression using adenovirus vector-mediatad gene transfer sig- 
nificantly enhanced the capacity of grafts to activate protein C and resulted in a near 80% 
reduction in bound thrombin activity on day 7, to levels comparable to normal veins (5.7" 
0.4 vs. 5.2 " 1.1 mU/cm 2, respectively, p= 0.74). Surprisingly, neointima formation was 
not affected by this inhibition of local thrombin generation. Conclusions: These results 
suggest that eady loss of TM expression enhances local thrombin generation that con- 
tributes to early vein graft failure due to thrombosis, but does not contribute significantly 
to late vein graft failure due to neointimal hyperplasia. 
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411-3 Improvement in Diastolic Suction In Patients With 
Hypertrophic Obstructive Cardiomyopathy After Septsl 
Ablation 
Aleksendr Rovner. Marta Sitges, Rebecca Smith, Nell L. Greanborg, Irmian Yiassak, 
Takahiro Shiota, Murat E. Tuzcu, Nicholas Smadira, Harry M. Lever, James D. Thomas, 
Mario J. Garcia, Department of Cardiovascular Medicine, The Clave~and C/inic 
Foundation, C/eve/and, Ohio. 
Background: Saptal alcohol ablation (PTSA) is an effective treatment in hypertrophic 
obstructive cardiomyopathy (HOCM). Intraventricuiar pressure gradient (IVPG) is a novel 
method to evaluate diastolic function. Our aim was to analyze the IVPG and diastolic 
function in HOCM patients with PTSA. 
Methods: 19 patients had an echocardiogram performed at baseline end after PTSA 
(mean follow up 5.6-J:1.2 months). Diastolic parameters were obtained using PW-Doppler 
through the mitral valve (E, A, DT), pulmonary venous flow (S, D), mitral annulus tissue 
Doppler imaging (Ea). Color M-mode was used to obtain the flow propagation velocity 
(Vp) through the mitral valve and to calculate IVPG oft-line using custom written soft- 
ware. LV dimensions were obtained. LV outflow tract (LVOT) gradient was calculated. 
Results: LVOT gradient decreased from 62±10 to 29:t:5 mmHg (p<0.001), severity of 
mitrel regurgitation (MR) decreased from 2.1:L-0.2 to 1.3!-0.2 (p<0.01). The septal size 
decreased from 2.3i~-0.09 to 1.9t0.05 mm (p<0.01). Diastolic results are shown in the 
Table. 
IVPG Vp (era/ E/A DT (ms) S/D EWp E/Ea 
(mmHg) s) 
Pre 1.5t-0.2 48+5 1.5±0.2 258±15 1.2!-0.1 2.2_+0.2 14.?_.-~.5 
Post 2.6+0.3* 74+7* 0.9t-0.1" 256+12 1.3-~0.1 1.3i0.1" 11.3±1.3 
*p<0.01 vs Pre. 
The increase in IVPG correlated with the increase in Vp (r=0.5) and with the decrease in 
LVOT gradient (r=-0.6), F_Np (r=-0.5), E/Ea (r=-0.7), (all p<0.05), and decrease in MR 
(r=-0.7, p<0.01). No correlation was found between the increase in IVPG and decrease in 
E/A, S/D and DT. 
Conclusion: IVPG is a reliable indicator of diastolic function improvement in HOCM after 
PTSA as indicated by the increase in IVPG and change in other diastolic parameters. 
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411-4 L-Arginine Protects Human Heart Cells From Simulated 
Anoxia and Reoxgenation 
Subodh Verma. Noritsugu Shiono, Ran-Ks Li, Donald A. Miokle, Paul W. Fedak, Richard 
D. Waissf, University of Toronto, Toronto, Ontario, Canada. 
The present study was conducted to evaluate the direct affects of L-arginine in a human 
ventricular heart cell model of simulated isohemia and reperfusion independent of alter- 
nate cell types such as endothelial cells, neutrophils, platelets or fibroblasts. Human ven- 
tdcuiar heart call cultures were subjected to 90 minutes of low volume isohemia and 30 
minutes of reperfusion. L-arginina (0-5.0 mM) was administered udng the pre-ischemic 
period or dudng the reperfusion phase. Nitric oxide synthase (NOS) activity, nitric oxide 
(NO) production, cGMP levels and cellular injury were assessed. To evaluate the effects 
of L-arginine on cell signaling, the effects of NOS antagonist (L-NAME), NO donor 
(SNAP), guanylate cyciase inhibitor (methylene blue), cGMP analogue (8-BrCGMP) and 
KAT P antagonist (glibenclamide) were examined. Our data indicate, that ischemia and 
reperfusion increased NOS activity and facilitated the conversion of L-arginine to NO, 
